Skip to Content

New Haven Pharmaceuticals, Inc.

Address

New Haven Pharmaceuticals, Inc.,
Espero Pharmaceuticals Inc. has acquired worldwide rights to New Haven Pharmaceuticals Inc.’s FDA-approved Durlaza (aspirin) extended-release capsules. February 2017.

Contact Details

Website: https://www.drugs.com/manufacturer/espero-pharmaceuticals-inc-575.html

Hide